GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Shanghai Fosun Pharmaceutical Group Co 600196.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

23.11

-1.99%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥41.50bn

FY2016FY2025

Net income

CN¥3.37bn

FY2016FY2025

Free cash flow

CN¥1.56bn

FY2016FY2025

Shareholders' equity

CN¥48.74bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥41.50bnCN¥41.07bnCN¥41.40bnCN¥43.95bnCN¥39.01bnCN¥30.31bnCN¥28.59bnCN¥24.92bnCN¥18.53bnCN¥14.63bn
Gross profitCN¥19.12bnCN¥19.64bnCN¥19.68bnCN¥20.70bnCN¥18.72bnCN¥16.51bnCN¥17.03bnCN¥14.54bnCN¥10.91bnCN¥7.87bn
Research and developmentCN¥3.56bnCN¥3.68bnCN¥4.37bnCN¥4.30bnCN¥3.99bnCN¥2.80bnCN¥2.04bnCN¥1.48bnCN¥1.03bnCN¥714.7m
Operating incomeCN¥2.52bnCN¥4.25bnCN¥3.31bnCN¥4.66bnCN¥6.30bnCN¥4.72bnCN¥4.49bnCN¥3.54bnCN¥4.07bnCN¥3.39bn
Net incomeCN¥3.37bnCN¥2.77bnCN¥2.39bnCN¥3.73bnCN¥4.73bnCN¥3.66bnCN¥3.32bnCN¥2.71bnCN¥3.12bnCN¥2.81bn
Diluted earnings per share1.281.040.891.401.841.441.331.011.241.20

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥120.47bnCN¥117.46bnCN¥113.47bnCN¥107.16bnCN¥93.29bnCN¥83.69bnCN¥76.12bnCN¥70.55bnCN¥61.97bnCN¥43.77bn
Cash and short-term investmentsCN¥15.36bnCN¥16.12bnCN¥15.58bnCN¥17.17bnCN¥14.55bnCN¥11.93bnCN¥9.99bnCN¥9.16bnCN¥7.47bnCN¥6.04bn
Total liabilitiesCN¥57.97bnCN¥57.53bnCN¥56.85bnCN¥53.05bnCN¥44.92bnCN¥37.70bnCN¥36.92bnCN¥36.96bnCN¥32.23bnCN¥18.52bn
DebtCN¥36.71bnCN¥31.70bnCN¥30.28bnCN¥30.25bnCN¥24.25bnCN¥24.01bnCN¥21.91bnCN¥23.21bnCN¥20.29bnCN¥11.22bn
Shareholders' equityCN¥48.74bnCN¥47.26bnCN¥45.68bnCN¥44.58bnCN¥39.19bnCN¥37.00bnCN¥31.89bnCN¥27.98bnCN¥25.33bnCN¥22.19bn
Shares outstanding2,640m2,663m2,670m2,670m2,570m2,548m2,489m2,668m2,518m2,333m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥6.01bnCN¥4.48bnCN¥4.36bnCN¥4.22bnCN¥3.95bnCN¥2.58bnCN¥3.22bnCN¥2.95bnCN¥2.58bnCN¥2.11bn
Capital spending−CN¥4.45bn−CN¥4.41bn−CN¥5.34bn−CN¥5.89bn−CN¥4.97bn−CN¥4.44bn−CN¥3.96bn−CN¥3.17bn−CN¥2.17bn−CN¥1.92bn
Free cash flowCN¥1.56bnCN¥66.8m−CN¥973.4m−CN¥1.67bn−CN¥1.02bn−CN¥1.86bn−CN¥739.6m−CN¥224.8mCN¥409.6mCN¥188.1m
Dividends paid−CN¥844.7m−CN¥2.06bn−CN¥2.46bn−CN¥1.44bn−CN¥1.10bn−CN¥1.00bn−CN¥818.6m−CN¥1.78bn−CN¥1.43bn−CN¥1.19bn

Latest quarters

By quarter end

Sept 2026Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024
RevenueCN¥10.02bnCN¥10.37bnCN¥10.07bnCN¥12.27bnCN¥9.88bnCN¥10.09bnCN¥9.42bnCN¥10.16bn
Gross profitCN¥4.99bnCN¥5.15bnCN¥5.01bnCN¥6.27bnCN¥4.78bnCN¥4.87bnCN¥4.50bnCN¥4.62bn
Operating incomeCN¥907.6mCN¥604.1mCN¥818.8mCN¥723.1mCN¥572.0mCN¥1.40bnCN¥1.36bnCN¥1.14bn
Net incomeCN¥946.0mCN¥850.6mCN¥870.8mCN¥847.3mCN¥821.3mCN¥937.2mCN¥764.8mCN¥759.2m
Diluted earnings per share0.360.320.330.320.310.360.290.29
Cash from operations———CN¥2.40bnCN¥1.34bnCN¥1.08bnCN¥1.05bnCN¥1.56bn
Capital spending−CN¥1.84bn−CN¥1.34bn−CN¥1.09bn−CN¥1.28bn−CN¥1.09bn−CN¥955.0m−CN¥1.12bn−CN¥1.38bn
Free cash flow———CN¥1.12bnCN¥245.0mCN¥123.0m−CN¥63.0mCN¥176.0m
Total assetsCN¥126.79bnCN¥125.43bnCN¥122.97bnCN¥120.47bnCN¥118.12bnCN¥118.83bnCN¥117.99bnCN¥117.46bn
Cash and short-term investments———CN¥15.36bnCN¥13.51bnCN¥15.64bnCN¥16.07bnCN¥16.12bn
DebtCN¥15.45bnCN¥13.02bnCN¥12.58bnCN¥33.66bnCN¥22.94bnCN¥29.46bnCN¥34.19bnCN¥29.15bn
Shareholders' equityCN¥50.30bnCN¥48.73bnCN¥49.15bnCN¥48.74bnCN¥48.03bnCN¥47.40bnCN¥47.92bnCN¥47.26bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-1.9%6.5%12.7%
Operating income-18.5%-11.8%-2.6%
Net income-3.3%-1.6%3.2%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin46.9%47.1%48.2%50.8%
Operating margin8.2%8.8%10.9%13.2%
Net margin7.4%7.3%8.7%10.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings20.723.928.025.226.637.519.922.935.919.2
Price to sales1.71.61.62.13.24.52.32.56.03.7

Dividends and splits

Per share, in the currency the company pays

Paid for 25 years. Last went ex-dividend on 27 Jul 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.390.320.270.420.560.430.390.32
  • 13-for-10 split · 8 Jun 2007
  • 2-for-1 split · 24 Jun 2004
  • 13-for-10 split · 18 Jun 2002
  • 6-for-5 split · 31 Mar 2000
  • 3-for-2 split · 2 Feb 1999

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.